Genetic Modifiers for 22q11.2 Syndrome

First posted Jun 10, 2009

Non-Invasive Chromosomal Evaluation of 22q11.2

420 participants · First posted Sep 4, 2015

Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study

First posted Mar 11, 2005

drug candidate (22q11.2 Deletion Syndrome)

Drug Candidate for 22q11.2 Deletion Syndrome (Herophilus)

22q11 Deletion Syndrome(Aelis Farma)

Nobias Therapeutics' NB-001 Shows Promise for 22q11.2 Deletion Syndrome

Antioxidant Therapy Bypasses Genetic Defect in 22q11.2 Deletion Syndrome via Alternative Gene Networks

Synaptiq Therapeutics Launches with Acquisition of SYN-001, a Phase II-Ready Small Molecule for 22q11.2 Deletion Syndrome